CRL Charles River Laboratories International PE ratio, current and historical analysis
As of Apr 25, 2025, the CRL stock has a PE ratio of 573.3. The calculation is based on the latest EPS of $0.2 and the stock price of $114.66 per share. An increase of 127% has been observed in the PE ratio compared to its average of 252.9 of the last four quarters.
CRL PE ratio history
The mean historical PE ratio of Charles River Laboratories International over the last ten years is 53.32. The current 573.3 P/E ratio is similar to the historical average. Looking back at the last ten years, CRL's PE ratio peaked in the Dec 2024 quarter at 930.8, with a price of $186.16 and an EPS of $0.2. The Apr 2023 quarter marked the lowest point at 20.68, with a price of $201.82 and an EPS of $9.76.
Charles River Laboratories International PE ratio by year
Maximum annual increase: 3,550.2% in 2024
Maximum annual decrease: -52.08% in 2022
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 930.8 | 3,550.2% | $186.16 | $0.2 |
| 2023 | 25.5 | 11.99% | $236.4 | $9.27 |
| 2022 | 22.77 | -52.08% | $217.9 | $9.57 |
| 2021 | 47.52 | 38.74% | $369.2 | $7.77 |
| 2020 | 34.25 | 16.54% | $251.71 | $7.35 |
| 2019 | 29.39 | 24.17% | $151.93 | $5.17 |
| 2018 | 23.67 | -43.78% | $111.72 | $4.72 |
| 2017 | 42.1 | 81.78% | $109.45 | $2.6 |
| 2016 | 23.16 | -7.17% | $76.19 | $3.29 |
| 2015 | 24.95 | 5.54% | $80.08 | $3.21 |
| 2014 | 23.64 | -4.68% | $64.29 | $2.72 |
| 2013 | 24.8 | 36.49% | $53.33 | $2.15 |
| 2012 | 18.17 | 43.64% | $36.88 | $2.03 |
| 2011 | 12.65 | N/A | $27.33 | $2.16 |
| 2010 | N/A | N/A | $35.7 | -$5.38 |
Charles River Laboratories International PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Dec 2024 | 930.8 | 3,679.13% | $186.16 | $0.2 |
| Sep 2024 | 24.63 | 0.29% | $198.31 | $8.05 |
| Jun 2024 | 24.56 | -22.5% | $206.58 | $8.41 |
| Mar 2024 | 31.69 | 24.27% | $270.95 | $8.55 |
| Dec 2023 | 25.5 | 21.03% | $236.4 | $9.27 |
| Sep 2023 | 21.07 | -4.79% | $195.98 | $9.3 |
| Jul 2023 | 22.13 | 7.01% | $210.25 | $9.5 |
| Apr 2023 | 20.68 | -9.18% | $201.82 | $9.76 |
| Dec 2022 | 22.77 | 4.69% | $217.9 | $9.57 |
| Sep 2022 | 21.75 | -15.73% | $187.51 | $8.62 |
| Jun 2022 | 25.81 | -22.52% | $226.32 | $8.77 |
| Mar 2022 | 33.31 | -29.9% | $279.1 | $8.38 |
| Dec 2021 | 47.52 | -17.88% | $369.2 | $7.77 |
| Sep 2021 | 57.87 | 24.88% | $458.3 | $7.92 |
| Jun 2021 | 46.34 | 21.31% | $367.9 | $7.94 |
CRL average PE ratio chart
CRL's current PE ratio is higher than the 3, 5 and 10-year averages.
CRL PE vs peers
In comparison to its peer stock TMO, CRL's PE ratio is higher.
| Stock name | PE ratio | Market cap |
|---|---|---|
| TMO Thermo Fisher Scientific Inc | 25.59 | $160.05B |
| CRL Charles River Laboratories International Inc | 573.3 | $5.86B |
| RGEN Repligen Corp | N/A | $8.13B |
| SCYX Scynexis Inc | N/A | $39.76M |
Frequently asked questions
What is Charles River Laboratories International's PE ratio?
CRL stock has a price to earnings ratio of 573.3 as of Apr 25, 2025.
What is the 3-year average PE ratio for Charles River Laboratories International (CRL)?
As an average over the last 3 years, CRL stock has a PE ratio of 106.49.
What is the 5-year average PE ratio for Charles River Laboratories International (CRL)?
As an average over the last 5 years, CRL stock has a PE ratio of 78.7.
What is the highest PE ratio for CRL?
Over the last ten years, the Dec 2024 quarter recorded the highest quarterly PE ratio at 930.8.
How does the current PE ratio for CRL compare to its historical average?
CRL's current price to earnings ratio is 975% above its 10-year historical average.
Why is Charles River Laboratories International's PE ratio so high?
CRL's PE ratio is high because its earnings per share (EPS) is low relative to its stock price.
How is CRL's PE ratio calculated (Charles River Laboratories International PE ratio formula)?
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Apr 25, 2025), Charles River Laboratories International's share price is $114.66. The company's earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $0.2. Therefore, Charles River Laboratories International's PE ratio for today is 573.3. PE RATIO(573.3) = STOCK PRICE($114.66) / TTM EPS($0.2)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.